ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition

Thursday, December 4, 2008 General News J E 4
RANCHO CORDOVA, Calif., Dec. 3 ThermoGenesisCorp. (Nasdaq: KOOL), a leading supplier of innovative products and servicesthat process and store adult stem cells, said today that it will hold aconference call on Thursday, December 4, to discuss its announcement regardinga management transition at the Company.

The conference call will begin at 5:30 a.m., Pacific Standard Time(8:30 a.m., Eastern Standard Time). The call can be accessed by calling(800) 860-2422 (domestic) or (412) 858-4600 (international), passcodeThermoGenesis. The webcast will also be available on the Company's website at

A replay of the call will be available by calling (877) 344-7529(domestic), or (412) 317-0088 (international), passcode 385107#, or via theCompany's website.

About ThermoGenesis Corp.

ThermoGenesis Corp. ( is a leading supplierof innovative products and services that process and store adult stem cellsfor treatment of disease and injury.

This press release contains forward-looking statements, and suchstatements are made pursuant to the safe harbor provisions of the PrivateSecurities Litigation Reform Act of 1995. These statements involve risks anduncertainties that could cause actual outcomes to differ materially from thosecontemplated by the forward-looking statements. Several factors, includingtiming of FDA approvals, changes in customer forecasts, our failure to meetcustomers' purchase order and quality requirements, supply shortages,production delays, changes in the markets for customers' products,introduction timing and acceptance of our new products scheduled for fiscalyear 2009, and introduction of competitive products and other factors beyondour control, could result in a materially different revenue outcome and/or inour failure to achieve the revenue levels we expect for fiscal 2009. A morecomplete description of these and other risks that could cause actual eventsto differ from the outcomes predicted by our forward-looking statements is setforth under the caption "Risk Factors" in our annual report on Form 10-K andother reports we file with the Securities and Exchange Commission from time totime, and you should consider each of those factors when evaluating theforward-looking statements.ThermoGenesis Corp. Web site: Contact: Investor Relations +1-916-858-5107, or

SOURCE ThermoGenesis Corp.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
MAP Pharmaceuticals to Present at the 2008 RBC Cap...
Belmont(R) Rapid Infuser Helps Save Officer's Life